Trials / Completed
CompletedNCT05369494
Infants Fed a Hydrolyzed Infant Formula
Tolerance of Infants Fed a Hydrolyzed Infant Formula
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 33 (actual)
- Sponsor
- Abbott Nutrition · Industry
- Sex
- All
- Age
- 0 Days – 90 Days
- Healthy volunteers
- Not accepted
Summary
The purpose of this non-randomized, multi-center study is to evaluate the growth, tolerance and compliance of an extensively hydrolyzed infant formula in an intended use population of infants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Hydrolyzed protein infant formula with oligosaccharides | Hydrolyzed protein infant formula with oligosaccharides |
Timeline
- Start date
- 2022-05-07
- Primary completion
- 2023-06-23
- Completion
- 2023-11-18
- First posted
- 2022-05-11
- Last updated
- 2024-05-01
Locations
7 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT05369494. Inclusion in this directory is not an endorsement.